Never works...

Quote






what you say above may wind up ending true, but you cannot blame the layoffs for the upcoming poor Q2 sales earnings and delay in the August 4th earnings date (have they announced a new earning date yet ?)

Give the changes some time. But I am curious as to why you say mgmt. is clueless (again it may be true). Can you give some specifics of the problem and what needs to be done to correct in you opinion.

Thanks in advance

The WS Grinder
 






They are clueless:

Their plan going forward is to leave money on the table and focus on call metrics and not sales. They think metrics brings sales. As reps we go to where the business is and not to satisfy the metric.

The reps can only do so much without the support of managed care and pricing. There are not many providers that does not think our products are superior to the competition and generics. Except generics and competitions are easier to get for the patients at a lower cost.

Without the muscle and finance of a larger and more well funded company we are fighting an uphill battle with both hands tie behind our back.

Reps will be intimidated and threaten for better metrics. True productivity will fall because management will be hanging on to save their jobs and not care about the company less of the customers and patients.
 












To understand what is going on in the field rely less on metrics and what your middle managers are telling you and get off your butt and see first hand. None of these top managers travel with their reps. You can actually see a reps value. No milk runs! Find out who is making a contribution and who is going through the motions. Sit back in the ivory tower, look at numbers and listen to what others tell you and you are flying blind and you get what you deserve. Don't tell me they don't have time. This is their job!
 






Metrics is what got Pernix where it is. There were reps only going thru the motions-have to hit those 8 calls & do the reach.
Maybe the 21 neuro & 33 pain reps that were let go were trying to build business where non was due to poor managecare coverage. Or their territories were so big the reach & frequency made absolutely no sense whats so ever
 






With blowout Q2 earnings report expected, they can probably afford to let a few reps go to save money and increase efficiency. Sales have reached all time highs in the last couple months and management has made the moves necessary to start "packaging" PTX for a potential buyout.
 


















I would never invest in this company. Upper management has no clue of what they are doing, the interim CEO is trusting theses idiots to make decisions in business units where they have no experience. This sales realignment is the death of Pernix.
 






anonymous said:
I would never invest in this company. Upper management has no clue of what they are doing, the interim CEO is trusting theses idiots to make decisions in business units where they have no experience. This sales realignment is the death of Pernix.
Click to expand...
I would agree. The beginning of the end was when they had 2 sales teams only sale 2 products. Company should have realigned when Zogenix came onboard and then have everyone sell 3 products. These are not difficult product to sell....deal was and still is that there is no managecare coverage. So having just over 100 reps to sell products is like a sinking ship...the Titanic...its going down...how fast or slow depends on management
 






anonymous said:
I would never invest in this company. Upper management has no clue of what they are doing, the interim CEO is trusting theses idiots to make decisions in business units where they have no experience. This sales realignment is the death of Pernix.
Click to expand...

Would you invest in this company if one share was on $.50?
 






No I wouldn't touch this stock as the worse hasn't happened yet. Your. 50 will be zero if a miracle financially doesn't happen soon.

Why. Do you think NO insiders (mgmt or employees have bought any shares since. 2015). Sinking ship.
 












Top Bottom
Back
Quote